Found: 14
Select item for more details and to access through your institution.
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications.
- Published in:
- 2019
- By:
- Publication type:
- journal article
bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses.
- Published in:
- Database: The Journal of Biological Databases & Curation, 2021, v. 2021, p. 1, doi. 10.1093/database/baab007
- By:
- Publication type:
- Article
bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses.
- Published in:
- Database: The Journal of Biological Databases & Curation, 2013, v. 2013, p. 1, doi. 10.1093/database/bas060
- By:
- Publication type:
- Article
bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 131, n. 3, p. 765, doi. 10.1007/s10549-011-1457-7
- By:
- Publication type:
- Article
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.781121
- By:
- Publication type:
- Article
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.
- Published in:
- Breast Cancer Research, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13058-015-0550-y
- By:
- Publication type:
- Article
Gene-expression signature functional annotation of breast cancer tumours in function of age.
- Published in:
- BMC Medical Genomics, 2015, v. 8, p. 1, doi. 10.1186/s12920-015-0153-6
- By:
- Publication type:
- Article
iTRAQ‐Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple‐Negative Breast Cancer Tumors.
- Published in:
- Proteomics, 2019, v. 19, n. 21/22, p. N.PAG, doi. 10.1002/pmic.201800484
- By:
- Publication type:
- Article
Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e244435, doi. 10.1001/jamanetworkopen.2024.4435
- By:
- Publication type:
- Article
Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 2, p. 426, doi. 10.1002/ijc.26397
- By:
- Publication type:
- Article
DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma.
- Published in:
- Clinical Epigenetics, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13148-020-00953-y
- By:
- Publication type:
- Article
Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 446, doi. 10.1002/hon.2750
- By:
- Publication type:
- Article
Prevalence of Proton Pump Inhibitor Use Among Patients With Cancer.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 6, p. e2113739, doi. 10.1001/jamanetworkopen.2021.13739
- By:
- Publication type:
- Article
How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology.
- Published in:
- Current Oncology, 2024, v. 31, n. 6, p. 3513, doi. 10.3390/curroncol31060259
- By:
- Publication type:
- Article